PT. KalGen DNA

medical devices

About

PT. KalGen DNA is a biotechnology company established in 2012 through a partnership between PT Bifarma Adiluhung and DNA Laboratories Sdn. Bhd. The company specializes in developing and marketing molecular diagnostic kits aimed at enhancing human health and personalized healthcare. Key products include the Elva Diagnostic SARS-CoV-2 Real-time RT-PCR Kit for detecting COVID-19 and the INDIGEN MTB/NTM/DR-TB Real Time PCR Kit Gen. 2 for diagnosing tuberculosis and drug resistance. PT. KalGen DNA emphasizes quality and innovation, supported by certifications such as WHO LabNet proficiency and ISO 13485. The company collaborates with laboratories to promote cervical cancer screening, reflecting its commitment to preventive healthcare. PT. KalGen DNA serves healthcare providers, diagnostic laboratories, and public health programs in Indonesia, focusing on infectious disease detection and genetic screening. The company imports essential materials from Malaysia and the United States and exports its diagnostic products, leveraging strategic partnerships to enhance its supply chain.

Technologies

Outlook Microsoft Office 365 Amazon AWS Mobile Friendly Google Font API

Keywords

cervical cancer screening & hpv test hpv test cervical cancer screening diagnostic kit covid19 screening medical equipment manufacturing nucleic acid amplification services diagnostic manufacturing hpv genotyping oncology diagnostics real-time pcr healthcare equipment & supplies manufacturing t790m mutation detection nucleic acid amplification technology mutation detection hpv 16/18 detection medical equipment and supplies manufacturing healthcare technology sars-cov-2 testing b2b in-vitro diagnostics medical diagnostics high-risk hpv detection tb detection pcr kits covid-19 testing genotyping kits mutation analysis medical laboratories

Location

23 Jalan Pulogadung, Jakarta, Special Capital Region of Jakarta, Indonesia, 13240

Related Companies

Companies in the same industry